Combinatorial treatment of glioblastoma with temozolomide (TMZ) plus 5-ethynyl-2′-deoxyuridine (EdU)
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Proceedings of the National Academy of Sciences, Volume 123, Number 1, January 2026.
Importance Glioblastoma (GBM) is a devastating disease with limited treatment options. We find that EdU, in combination with the currently used anticancer drug TMZ, produces very significant survival benefits and synergistic effects in preclinical GBM…
